Workflow
Benzinga
icon
Search documents
Golden Cross Alert: Uranium Giant Cameco Ignites Nuclear Rally With Bullish Breakout
Benzinga· 2025-06-20 15:39
Group 1 - Cameco Corp. has seen a significant increase in its stock price, up over 30% year-to-date and matching a 30% gain over the past month, indicating a strong bullish trend [1][2] - The stock has surpassed its eight, 20, and 50-day simple moving averages (SMAs), with the current share price at $68.08 compared to the 50-day SMA of $52.72, highlighting the strength of the uptrend [2] - The Moving Average Convergence Divergence (MACD) is at 4.68, supporting a bullish outlook, while the Relative Strength Index (RSI) is at 71.20, indicating that buyers remain in control despite nearing overbought territory [3] Group 2 - There is a growing investor appetite for nuclear energy, driven by increasing global interest in low-carbon power solutions, which is positively impacting Cameco's market position [4] - As uranium demand rises and sentiment shifts towards nuclear as a clean-energy alternative, Cameco is increasingly recognized as a leading pure play in the nuclear energy sector [4]
These Analysts Boost Their Forecasts On GMS
Benzinga· 2025-06-20 15:24
Core Insights - GMS Inc. reported better-than-expected fourth-quarter fiscal 2025 results, with net sales of $1.33 billion, surpassing analyst estimates of $1.30 billion, despite a 5.6% decrease from the previous year [1] - The adjusted EPS of $1.29 exceeded the consensus estimate of $1.11, indicating strong performance amid challenging market conditions [1][2] - GMS received an unsolicited buyout proposal of $95.20 per share from QXO, leading to a 28.3% increase in GMS shares, which traded at $103.92 [2] Analyst Ratings and Price Targets - Stephens & Co. analyst Trey Grooms maintained an Overweight rating and raised the price target from $90 to $95 [4] - RBC Capital analyst Mike Dahl maintained a Sector Perform rating and increased the price target from $65 to $95.2 [4] - Barclays analyst Matthew Bouley kept an Equal-Weight rating and raised the price target from $71 to $95 [4] - Raymond James analyst Sam Darkatsh maintained an Outperform rating and increased the price target from $80 to $90 [4]
Circle Stock Rockets 540%: Cathie Wood Says 'We've Just Begun'
Benzinga· 2025-06-20 15:16
Circle Internet Group, Inc. CRCL, the issuer behind the USD Coin USDC/USD stablecoin, has stunned Wall Street with a meteoric 540% surge since its IPO on June 5. The stock closed at $199.59 on Wednesday, propelling Circle's valuation to nearly $50 billion. What To Know: Circle's explosive rally gained more momentum Wednesday after the U.S. Senate's passage of the GENIUS Act, a landmark bill that would formally regulate dollar-backed stablecoins and integrate them into the U.S. financial system. Read Next: S ...
Dow Surges Over 100 Points; Accenture Posts Upbeat Earnings
Benzinga· 2025-06-20 14:14
Company Performance - Accenture Plc reported third-quarter earnings of $3.49 per share, exceeding the analyst consensus estimate of $3.31 [2] - The company achieved sales of $17.7 billion, slightly above the analyst consensus estimate of $17.30 billion, with an 8% increase in U.S. dollars and a 7% increase in local currency [2] - Accenture narrowed its fiscal year 2025 revenue growth outlook to 6%-7% in local currency, up from a prior range of 5%-7% [3] - The company forecasts diluted earnings for 2025 to be between $12.77 and $12.89 per share, compared to the previous estimate of $12.55-$12.79 and the consensus of $12.75 [3] Market Movements - Wheeler Real Estate Investment Trust, Inc. shares surged 159% to $8.85 following the announcement of a 1-for-7 reverse stock split [9] - Dragonfly Energy Holdings Corp. shares increased by 74% to $0.3796 after a 6% gain on Wednesday [9] - Innovative Eyewear, Inc. shares rose 73% to $3.9502 after announcing a partnership with Smartech Retail Group [9] - Nature Wood Group Limited shares dropped 59% to $2.2950 after a previous surge of over 142% [9] - Moleculin Biotech, Inc. shares fell 48% to $0.3040 due to a $5.9 million public offering announcement [9] - Regencell Bioscience Holdings Limited shares decreased by 48% to $32.99 after a decline of over 18% on Wednesday [9]
Marvell Technology: Stock Levels Look Right, Here's What To Watch
Benzinga· 2025-06-20 13:42
Core Insights - Marvell Technology (MRVL) is currently in Phase 7 of its 18-phase Adhishthana Cycle, with a potential significant breakout anticipated in Phase 9 [1][10] - The stock has shown an 83.33% alignment with the Adhishthana Principles, indicating a strong cyclical structure [2] - The current phase involves an eight-bar corrective structure, with three red bars completed, and five more expected by March 31, 2026 [4] Current Structure and Alignment - MRVL is in Phase 7, characterized by the Fall of Artah and Artharthi pattern, indicating ongoing corrective movements [4] - The stock is forming a Cakra, a rounded cyclical base, with critical stages approaching as it nears the completion of this formation [5] - The Nirvana Level is identified at $42.77, acting as a valuation magnet that could influence future price movements [5][11] Weekly Chart Insight - On the weekly chart, MRVL is in Phase 17, which typically shows no action, and the Guna Triads indicate a lack of bullish momentum [9] - The absence of strength on the weekly chart supports the monthly setup, suggesting that the major breakout will occur in Phase 9 starting September 1, 2028 [10] Where Things Stand Now - The stock is near its Nirvana level of $42.77, which historically provides strong accumulation opportunities [11] - A potential rally up to the $110 mark is anticipated, followed by a short-term correction, which would be a healthy development for completing the Cakra [11] Investor Takeaway - Existing holders are advised to remain patient as a major breakout is expected in Phase 9 [13] - Potential buyers should monitor levels near the Nirvana zone for accumulation, as short-term corrections are part of a broader buildup [13]
DoorDash Rises 2.4% After Key Trading Signal
Benzinga· 2025-06-20 12:36
Core Insights - DoorDash Inc. (DASH) experienced a significant trading signal known as Power Inflow, indicating a potential uptrend in its stock price at $216.06, which is crucial for traders following institutional movements [2][6] - The Power Inflow is interpreted as a bullish signal by active traders, suggesting a favorable market condition for DoorDash [3][4] Trading Signal Analysis - The Power Inflow occurred within the first two hours of market open, which typically helps gauge the stock's overall direction for the remainder of the trading day, driven by institutional activity [4] - Following the Power Inflow, DoorDash's stock reached a high price of $221.31 and a close price of $220.59, resulting in returns of 2.4% and 2.1% respectively, highlighting the importance of a structured trading plan [8] Order Flow Analytics - Order flow analytics, which involves analyzing the flow of buy and sell orders, provides insights into market conditions and helps traders identify potential trading opportunities [3][5] - Incorporating order flow analytics into trading strategies can enhance trading performance, although effective risk management remains essential for capital protection [5]
Smith & Wesson Brands Posts Weak Q4 Results, Joins Aptevo Therapeutics And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Benzinga· 2025-06-20 12:01
Group 1 - U.S. stock futures are lower, with Dow futures down approximately 0.2% [1] - Smith & Wesson Brands reported fourth-quarter revenue of $140.8 million, missing analyst estimates of $152.41 million [2] - The company reported adjusted earnings of 20 cents per share, falling short of estimates of 23 cents per share [2] Group 2 - Smith & Wesson Brands shares fell 12.6% to $9.51 in pre-market trading [2] - Regencell Bioscience Holdings Ltd shares dropped 16.2% to $52.96 in pre-market trading [4] - QuantaSing Group Ltd- ADR shares fell 12.1% to $11.86 in pre-market trading [4] - Aptevo Therapeutics Inc shares decreased by 11.9% to $4.52 in pre-market trading [4] - Capricor Therapeutics Inc shares fell 7.4% to $11.04 in pre-market trading [4] - Mesoblast Ltd shares declined 6.5% to $10.94 in pre-market trading [4] - Diginex Limited shares dropped 6.5% to $43.51 in pre-market trading [4] - Himalaya Shipping Ltd. shares decreased 6.3% to $6.22 in pre-market trading [4] - AIRO Group Holdings, Inc. shares fell 5.3% to $24.88 in pre-market trading [4]
Wall Street's Most Accurate Analysts Spotlight On 3 Industrials Stocks Delivering High-Dividend Yields
Benzinga· 2025-06-20 11:37
Group 1: Market Trends - During turbulent market conditions, investors often seek dividend-yielding stocks, which typically have high free cash flows and offer substantial dividend payouts [1] - Analysts provide insights on high-yielding stocks, allowing traders to access a comprehensive database of ratings and accuracy [1] Group 2: Company Ratings and Performance - United Parcel Service, Inc. (UPS) has a dividend yield of 6.61%. Analyst Ken Hoexter from B of A Securities maintained a Buy rating and raised the price target from $111 to $115, with an accuracy rate of 62%. UPS reported a quarterly revenue decline of 0.7% year-over-year to $21.546 billion, surpassing the consensus estimate of $21.05 billion [7] - Copa Holdings, S.A. (CPA) has a dividend yield of 6.21%. Analyst Thomas Fitzgerald from TD Cowen maintained a Buy rating but reduced the price target from $145 to $130, with an accuracy rate of 64%. Recent earnings exceeded expectations [7] - Robert Half Inc. (RHI) has a dividend yield of 5.71%. Analyst Manav Patnaik from Barclays maintained an Equal-Weight rating and lowered the price target from $50 to $45, with an accuracy rate of 77%. The company reported worse-than-expected first-quarter financial results [7]
FactSet Research Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
Benzinga· 2025-06-20 11:01
Group 1 - FactSet Research Systems Inc. is set to release its third-quarter earnings results on June 23, with expected earnings of $4.30 per share, a decrease from $4.37 per share in the same period last year [1] - The company is projected to report quarterly revenue of $580.9 million, an increase from $552.71 million a year earlier [1] - Sanoke Viswanathan has been appointed as the new CEO, effective early September 2025, succeeding Phil Snow [2] Group 2 - RBC Capital analyst Ashish Sabadra has reiterated a Sector Perform rating with a price target of $503 [4] - BMO Capital analyst Jeffrey Silber maintained a Market Perform rating and reduced the price target from $498 to $466 [4] - UBS analyst Alex Kramm maintained a Neutral rating and lowered the price target from $525 to $480 [4] - Wells Fargo analyst Jason Haas downgraded the stock from Equal-Weight to Underweight, cutting the price target from $450 to $402 [4] - Morgan Stanley analyst Toni Kaplan maintained an Underweight rating and reduced the price target from $409 to $390 [4]
Top Wall Street Forecasters Revamp Commercial Metals Expectations Ahead Of Q3 Earnings
Benzinga· 2025-06-20 06:48
Commercial Metals Company CMC will release earnings results for the third quarter, before the opening bell on Monday, June 23.Analysts expect the Irving, Texas-based company to report quarterly earnings at 84 cents per share, down from $1.02 per share in the year-ago period. Commercial Metals projects to report quarterly revenue of $2.04 billion, compared to $2.08 billion a year earlier, according to data from Benzinga Pro.On March 20, Commercial Metals reported second-quarter 2025 results on Thursday, with ...